JP Stock MarketDetailed Quotes

4512 Wakamoto Pharmaceutical

Watchlist
  • 246
  • +7+2.93%
20min DelayMarket Closed Jul 12 15:00 JST
8.57BMarket Cap78.59P/E (Static)

Wakamoto Pharmaceutical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Wakamoto Pharmaceutical Earnings Date

Currency: JPY

Period

Q4 FY2024 Earnings

May 15, 2024

Revenue(YoY)

2.15B

-10.05%
EPS(YoY)

9.05

+1031.25%
Analyst Rating

No Data

Wakamoto Pharmaceutical Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 0 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: JPY

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
Feb 5, 20242024/Q31.968B / ----
Aug 4, 20232024/Q11.860B / ----
Feb 2, 20232023/Q32.248B / ----
Aug 4, 20222023/Q12.023B / ----
Feb 2, 20222022/Q32.259B / ----
DatePeriodRevenue/EstimateEarnings Call
Feb 5, 20242024/Q31.968B / ----
Aug 4, 20232024/Q11.860B / ----
Feb 2, 20232023/Q32.248B / ----
Aug 4, 20222023/Q12.023B / ----
Feb 2, 20222022/Q32.259B / ----

Unlock Free Earnings Estimates

Wakamoto Pharmaceutical Earnings Reports

  • Wakamoto Pharmaceutical: Extraordinary Report

    Jul 1 23:00 ET

  • Wakamoto Pharmaceutical: Confirmatory letter.

    Jun 28 02:21 ET

  • Wakamoto Pharmaceutical: Securities Report - 129th Fiscal Year (April 1, 2023 - March 31, 2024)

    Jun 28 02:19 ET

  • Wakamoto Pharmaceutical: (Correction/Numerical data correction) Partial correction of the 'March 2024 financial results briefing (Japan standard) (Non-consolidated)'.

    Jun 4 02:00 ET

    • Read more

    Analysis

    Analyst Rating

    No Data

    Price Target

    No Data

    Heat List
    JP
    Overall
    Symbol
    Latest Price
    %Chg